Restoring susceptibility to aminoglycosides: identifying small molecule inhibitors of enzymatic inactivation-Reference-Cited by-同舟云学术

Restoring susceptibility to aminoglycosides: identifying small molecule inhibitors of enzymatic inactivation

Published:2023 Issue:9 Volume:14 Page:1591-1602
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Magaña Angel J.¹,Sklenicka Jan¹,Pinilla Clemencia²,Giulianotti Marc²,Chapagain Prem³⁴^ORCID,Santos Radleigh⁵,Ramirez Maria Soledad¹,Tolmasky Marcelo E.¹^ORCID

Affiliation:

1. Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA

2. Center for Translational Science, Florida International University, Port St. Lucie, FL 34987, USA

3. Department of Physics, Florida International University, Miami, FL 33199, USA

4. Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, USA

5. Department of Mathematics, Nova Southeastern University, Fort Lauderdale, FL 33314, USA

Abstract

Growing resistance to antimicrobial medicines is a critical health problem that must be urgently addressed.

Funder

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/MD/D3MD00226H

Reference155 articles.

1. W. H. Organization , WHO consolidated guidelines on drug-resistant tuberculosis , Geneva , 2019

2. Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)

3. Aminoglycosides: An Overview

4. Aminoglycoside modifying enzymes